PF-01247324 is primarily investigated for its potential therapeutic applications in the field of oncology. It acts as a selective inhibitor of certain kinase enzymes that play a critical role in cancer cell proliferation and survival. By targeting these specific kinases, it aims to disrupt signaling pathways that promote tumor growth, making it a promising candidate for the treatment of various cancers. Research is ongoing to evaluate its efficacy, safety, and potential use in combination with other cancer therapies. Its development highlights the focus on precision medicine to improve outcomes for patients with specific molecular profiles.